{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:21:02Z","timestamp":1787509262217,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-104921RB-I00"],"award-info":[{"award-number":["PID2019-104921RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-138285OB-I00"],"award-info":[{"award-number":["PID2022-138285OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21-00259"],"award-info":[{"award-number":["PI21-00259"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ymthe.2025.01.049","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:11:41Z","timestamp":1738609901000},"page":"895-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Marta","family":"Garcia-Gomara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naroa","family":"Legarra-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Serena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Rojas-de-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Espelosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marcilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Perez-Mediavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosario","family":"Luquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angeles","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Cuadrado-Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garcia-Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.01.049_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.01.049_bib3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.01.049_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ymthe.2025.01.049_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","article-title":"Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson\u2019s disease","volume":"75","author":"Fedorow","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib6","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra\u00a0regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.01.049_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.25187","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymthe.2025.01.049_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0047-6374(83)90074-X","article-title":"Possible role of neuromelanin in the pathogenesis of Parkinson\u2019s disease","volume":"21","author":"Mann","year":"1983","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ymthe.2025.01.049_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.01.049_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.1989.tb01778.x","article-title":"Selective vulnerability of pigmented dopaminergic neurons in Parkinson\u2019s disease","volume":"126","author":"Hirsch","year":"1989","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ymthe.2025.01.049_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.049_bib12","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1038\/s41467-024-53168-7","article-title":"Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits","volume":"15","author":"Laguna","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.049_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2025.01.049_bib14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2009.01.012","article-title":"A critical evaluation of the ubiquitin-proteasome system in Parkinson\u2019s disease","volume":"1792","author":"Cook","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2025.01.049_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJM199601113340202","article-title":"Prevalence of parkinsonian signs and associated mortality in a community population of older people","volume":"334","author":"Bennett","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.01.049_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","article-title":"Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson\u2019s disease","volume":"75","author":"Fedorow","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9440(10)64369-6","article-title":"p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases","volume":"160","author":"Zatloukal","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib18","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","article-title":"Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62","volume":"62","author":"Kuusisto","year":"2003","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ncb0910-836","article-title":"Selective autophagy: ubiquitin-mediated recognition and beyond","volume":"12","author":"Kraft","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib20","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.049_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.02-0314fje","article-title":"Activation of microglia by human neuromelanin is NF-\u03baB-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson\u2019s disease","volume":"17","author":"Wilms","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.01.049_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","article-title":"\u03b1-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration","volume":"5","author":"Harms","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2025.01.049_bib23","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.049_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2025.01.049_bib26","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.01.049_bib27","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","article-title":"Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia","volume":"95","author":"Harrison","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.01.049_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1\u03b2, interleukin-6, epidermal growth factor and transforming growth factor-\u03b1 are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymthe.2025.01.049_bib29","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166814","article-title":"Identification of Clec7a as the therapeutic target of rTMS in alleviating Parkinson\u2019s disease: targeting neuroinflammation","volume":"1869","author":"Chen","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ymthe.2025.01.049_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2002-020354","article-title":"Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability","volume":"88","author":"Vermeer","year":"2003","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.01.049_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/molehr\/gag080","article-title":"Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells","volume":"9","author":"Fahnenstich","year":"2003","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.ymthe.2025.01.049_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2003.12.086","article-title":"The Ets transcription factor Fev is specifically expressed in the human central serotonergic neurons","volume":"357","author":"Maurer","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymthe.2025.01.049_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052118","article-title":"Phox2b Influences the Development of a Caudal Dopaminergic Subset","volume":"7","author":"Hoekstra","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.01.049_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2011.07.041","article-title":"The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social\u00a0defeat stress","volume":"62","author":"Hartmann","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymthe.2025.01.049_bib36","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1080\/15548627.2021.1904489","article-title":"Modulating FKBP5\/FKBP51 and autophagy lowers HTT (huntingtin) levels","volume":"17","author":"Bailus","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2025.01.049_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-023-02541-9","article-title":"Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex","volume":"145","author":"Matosin","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib38","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0242-18.2019","article-title":"The Disease-Associated Chaperone FKBP51 Impairs Cognitive Function by Accelerating AMPA Receptor Recycling","volume":"6","author":"Blair","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.ymthe.2025.01.049_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep06696","article-title":"The common functional FKBP5 variant rs1360780 is associated with altered cognitive function in aged individuals","volume":"4","author":"Fujii","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.01.049_bib40","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1172\/JCI69003","article-title":"Accelerated neurodegeneration through chaperone-mediated oligomerization of tau","volume":"123","author":"Blair","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.049_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06880-0","article-title":"Structure and pro-toxic mechanism of the human Hsp90\/PPIase\/Tau complex","volume":"9","author":"Oroz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.049_bib42","article-title":"Unravelling cell type-specific responses to Parkinson\u2019s Disease at single cell resolution","volume":"19","author":"Martirosyan","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2025.01.049_bib44","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/acs.jmedchem.0c02195","article-title":"Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors","volume":"64","author":"Bauder","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2025.01.049_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neurobiolaging.2018.01.020","article-title":"Locomotor differences in mice expressing wild-type human \u03b1-synuclein","volume":"65","author":"Giraldo","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2025.01.049_bib52","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.1922-21.2022","article-title":"Microglia Drive Pockets of Neuroinflammation in Middle Age","volume":"42","author":"Moca","year":"2022","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-020-00585-6","article-title":"Aging-related motor function and dopaminergic neuronal loss in C57BL\/6 mice","volume":"13","author":"Noda","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ymthe.2025.01.049_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2016.11.015","article-title":"Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat\/maneb toxicity in mice","volume":"51","author":"Richter","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2025.01.049_bib55","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/glia.23834","article-title":"Microglia senescence occurs in both substantia nigra and ventral tegmental area","volume":"68","author":"Shaerzadeh","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2025.01.049_bib56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"104","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0197-4580(97)00169-3","article-title":"Age-Related Activation of Microglia and Astrocytes: In\u00a0Vitro Studies Show Persistent Phenotypes of Aging, Increased Proliferation, and Resistance to Down-Regulation","volume":"19","author":"Rozovsky","year":"1998","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.ymthe.2025.01.049_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","article-title":"Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ymthe.2025.01.049_bib59","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","article-title":"Marked microglial reaction in normal aging human substantia nigra: Correlation with extraneuronal neuromelanin pigment deposits","volume":"114","author":"Beach","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0165-6147(88)90248-9","article-title":"Neuromelanin-containing neurons are selectively vulnerable in parkinsonism","volume":"9","author":"Langston","year":"1988","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib61","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awv395","article-title":"Immunosenescence of microglia and macrophages: impact on the ageing central nervous system","volume":"139","author":"Rawji","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.01.049_bib62","doi-asserted-by":"crossref","first-page":"30152","DOI":"10.1074\/jbc.M111.256610","article-title":"The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress","volume":"286","author":"Gallo","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.049_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122614","article-title":"The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease","volume":"18","author":"Fries","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib64","doi-asserted-by":"crossref","first-page":"11370","DOI":"10.1073\/pnas.1816847116","article-title":"Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk","volume":"116","author":"Zannas","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.01.049_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122614","article-title":"The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease","volume":"18","author":"Fries","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib66","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/14756366.2019.1667342","article-title":"Blocking the FKBP12 induced dendrimeric burst in aberrant aggregation of \u03b1-synuclein by using the ElteN378 synthetic inhibitor","volume":"34","author":"Caminati","year":"2019","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.01.049_bib67","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1096\/fj.05-5126fje","article-title":"The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy","volume":"20","author":"Gerard","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.01.049_bib68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0031-9384(02)00934-4","article-title":"Immunophilins and their ligands: Insights into survival and growth of human neurons","volume":"77","author":"Avramut","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ymthe.2025.01.049_bib69","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1523\/JNEUROSCI.5983-09.2010","article-title":"Inhibition of FK506 Binding Proteins Reduces \u03b1-Synuclein Aggregation and Parkinson\u2019s Disease-Like Pathology","volume":"30","author":"Gerard","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib70","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1523\/JNEUROSCI.4815-09.2010","article-title":"The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules","volume":"30","author":"Jinwal","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-5-24","article-title":"Heat shock protein 90 in neurodegenerative diseases","volume":"5","author":"Luo","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2025.01.049_bib72","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2353\/ajpath.2006.050770","article-title":"Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies","volume":"168","author":"Uryu","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib73","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2174\/1389200218666170728115606","article-title":"Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer\u2019s and Parkinson\u2019s Diseases","volume":"18","author":"Alam","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ymthe.2025.01.049_bib74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroscience.2023.11.031","article-title":"Heat Shock Protein 90 in Parkinson\u2019s Disease: Profile of a Serial Killer","volume":"537","author":"Mansour","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2025.01.049_bib45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2353\/ajpath.2006.050770","article-title":"Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies","volume":"168","author":"Uryu","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.01.049_bib46","first-page":"1","article-title":"The cochaperone CHIP marks Hsp70- and Hsp90-bound substrates for degradation through a very flexible mechanism","volume":"91","author":"Quintana-Gallardo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.01.049_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06260-7","article-title":"FKBP5 activates mitophagy by ablating PPAR-\u03b3 to shape a benign remyelination environment","volume":"14","author":"Sun","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.01.049_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46953-x","article-title":"SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration","volume":"15","author":"Hartmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.049_bib48","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1080\/15548627.2024.2373675","article-title":"SKArred 2 death: neuroinflammatory breakdown of the hippocampus","volume":"20","author":"Bajaj","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2025.01.049_bib77","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","article-title":"A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation","volume":"22","author":"Grubman","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","article-title":"Aging and Parkinson\u2019s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis","volume":"115","author":"Calabrese","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ymthe.2025.01.049_bib79","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"Cabin","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib80","doi-asserted-by":"crossref","first-page":"9120","DOI":"10.3390\/ijms22179120","article-title":"Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer\u2019s Disease","volume":"22","author":"P\u00e9rez-Gonz\u00e1lez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.01.049_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.01.049_bib82","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.01.049_bib83","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:18:35Z","timestamp":1772673515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1525001625000875"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.049","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}